Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival
Dawood Khan, Srividya Vasu, R. Charlotte Moffett, et al.
Molecular and Cellular Endocrinology (2016) Vol. 436, pp. 102-113
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Therapies for Type 1 Diabetes: Current Scenario and Future Perspectives
Varun Pathak, Nupur Pathak, Christina O’Neill, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2019) Vol. 12
Open Access | Times Cited: 105
The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases—A Systematic Review and Meta-Analysis
Yuwei Wang, Jin Zhao, Yunlong Qin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes
Varun Pathak, Peter R. Flatt, Nigel Irwin
Peptides (2018) Vol. 100, pp. 229-235
Closed Access | Times Cited: 65
Calcium Signaling Pathways: Key Pathways in the Regulation of Obesity
Ziguo Song, Yu Wang, Fei Zhang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2768-2768
Open Access | Times Cited: 65
Emerging therapeutic potential for peptide YY for obesity-diabetes
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Peptides (2018) Vol. 100, pp. 269-274
Closed Access | Times Cited: 63
Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice
Marine L. Croze, Marcus F. Flisher, Arthur Guillaume, et al.
Molecular Metabolism (2021) Vol. 45, pp. 101166-101166
Open Access | Times Cited: 35
Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes
Wuyun Zhu, Neil Tanday, Peter R. Flatt, et al.
Peptides (2022) Vol. 160, pp. 170923-170923
Open Access | Times Cited: 26
Influence of neuropeptide Y and pancreatic polypeptide on islet function and beta-cell survival
Dawood Khan, Srividya Vasu, R. Charlotte Moffett, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2017) Vol. 1861, Iss. 4, pp. 749-758
Open Access | Times Cited: 45
Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Current Opinion in Endocrinology Diabetes and Obesity (2020) Vol. 28, Iss. 2, pp. 253-261
Open Access | Times Cited: 39
The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes
Claudia Guida, Sam D. Stephen, Romain Guitton, et al.
Trends in Endocrinology and Metabolism (2017) Vol. 28, Iss. 8, pp. 626-636
Open Access | Times Cited: 36
Oxytocin is present in islets and plays a role in beta-cell function and survival
Shruti Mohan, Dawood Khan, R. Charlotte Moffett, et al.
Peptides (2017) Vol. 100, pp. 260-268
Closed Access | Times Cited: 36
Ablation of somatostatin cells leads to impaired pancreatic islet function and neonatal death in rodents
Na Li, Zhao Yang, Qing Li, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 6
Open Access | Times Cited: 36
Cellular models for beta‐cell function and diabetes gene therapy
AD Green, Srividya Vasu, Peter R. Flatt
Acta Physiologica (2017) Vol. 222, Iss. 3
Closed Access | Times Cited: 35
The role of gut–islet axis in pancreatic islet function and glucose homeostasis
Qi Chen, Yuanyuan Gao, Fangyu Li, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
The role of endoplasmic reticulum stress in type 2 diabetes mellitus mechanisms and impact on islet function
Zhaxicao He, Qian Liu, Yan Wang, et al.
PeerJ (2025) Vol. 13, pp. e19192-e19192
Open Access
Vasopressin receptors in islets enhance glucose tolerance, pancreatic beta-cell secretory function, proliferation and survival
Shruti Mohan, R. Charlotte Moffett, Keith Thomas, et al.
Biochimie (2019) Vol. 158, pp. 191-198
Open Access | Times Cited: 29
PYY, a Therapeutic Option for Type 2 Diabetes?
Claudia Guida, Reshma Ramracheya
Clinical Medicine Insights Endocrinology and Diabetes (2020) Vol. 13, pp. 117955141989298-117955141989298
Open Access | Times Cited: 27
Beneficial actions of a long‐acting apelin analogue in diabetes are related to positive effects on islet cell turnover and transdifferentiation
Neil Tanday, Nigel Irwin, R. Charlotte Moffett, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 12, pp. 2468-2478
Open Access | Times Cited: 24
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
Ryan A. Lafferty, Neil Tanday, R. Charlotte Moffett, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 21
Construction of engineered 3D islet micro-tissue using porcine decellularized ECM for the treatment of diabetes
Xiaocheng Wang, Lijuan Jin, Wenyu Liu, et al.
Biomaterials Science (2023) Vol. 11, Iss. 16, pp. 5517-5532
Closed Access | Times Cited: 9
Sitagliptin and Roux‐en‐Y gastric bypass modulate insulin secretion via regulation of intra‐islet PYY
Claudia Guida, Laura McCulloch, Mahdieh Godazgar, et al.
Diabetes Obesity and Metabolism (2017) Vol. 20, Iss. 3, pp. 571-581
Open Access | Times Cited: 28
Locally produced xenin and the neurotensinergic system in pancreatic islet function and β-cell survival
Dawood Khan, Srividya Vasu, R. Charlotte Moffett, et al.
Biological Chemistry (2017) Vol. 399, Iss. 1, pp. 79-92
Closed Access | Times Cited: 27
Assessment of the potential of temporin peptides from the frog Rana temporaria (Ranidae) as anti‐diabetic agents
Vishal Musale, Bruno Casciaro, Maria Luisa Mangoni, et al.
Journal of Peptide Science (2018) Vol. 24, Iss. 2
Closed Access | Times Cited: 27
Effects of 2 Novel PYY(1-36) Analogues, (P3L31P34)PYY(1-36) and PYY(1-36)(Lys12PAL), on Pancreatic Beta-Cell Function, Growth, and Survival
Ryan A. Lafferty, Victor A. Gault, Peter R. Flatt, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2019) Vol. 12
Open Access | Times Cited: 25
Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β‐cell function, growth and survival
Ryan A. Lafferty, Neil Tanday, Andrew McCloskey, et al.
Diabetes Obesity and Metabolism (2019) Vol. 22, Iss. 3, pp. 404-416
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top